|
|
renal system development
|
GO:0072001 |
225 |
0.678
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.629
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.619
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.593
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.487
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.469
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.435
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.428
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.377
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.377
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.374
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.352
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.341
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.330
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.316
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.306
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.286
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.285
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.284
|
|
|
|
positive regulation of wnt signaling pathway planar cell polarity pathway
|
GO:2000096 |
5 |
0.282
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.275
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.265
|
Human |
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.263
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.254
|
Human |
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.245
|
|
|
|
positive regulation of non canonical wnt signaling pathway
|
GO:2000052 |
6 |
0.244
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.244
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.244
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.227
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.224
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.218
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.218
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.218
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.214
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.213
|
Human |
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.209
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.209
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.208
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.207
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.207
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.206
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.206
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.203
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.198
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.198
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.198
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.195
|
|
|
|
positive regulation of glycogen starch synthase activity
|
GO:2000467 |
4 |
0.193
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.191
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.188
|
|
|
|
regulation of wnt signaling pathway planar cell polarity pathway
|
GO:2000095 |
10 |
0.186
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.182
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.182
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.178
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.177
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.173
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.172
|
|
|
|
lung vasculature development
|
GO:0060426 |
7 |
0.172
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.171
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.170
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.167
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.166
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.165
|
|
|
|
chondroitin sulfate proteoglycan biosynthetic process
|
GO:0050650 |
8 |
0.163
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.159
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.158
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.157
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.154
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.146
|
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.143
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.143
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.142
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.142
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.142
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.140
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.140
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.137
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.136
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.132
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.131
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.131
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.131
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.130
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.130
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.129
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.128
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.127
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.127
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.125
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.123
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.120
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.120
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.120
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.119
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.119
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.117
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.116
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.116
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.115
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.114
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.114
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.113
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.110
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.110
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.110
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.110
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.109
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.109
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.108
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.107
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.106
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.106
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.106
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.105
|
|
|
|
prostate gland growth
|
GO:0060736 |
13 |
0.103
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.103
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.102
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.102
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.102
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.101
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.100
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.098
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.097
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.097
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.096
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.095
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.095
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.095
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.095
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.094
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.094
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.093
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.093
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.093
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.093
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.092
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.092
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.092
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.091
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.090
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.090
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.089
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.087
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.087
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.086
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.086
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.085
|
|
|
|
type i pneumocyte differentiation
|
GO:0060509 |
7 |
0.085
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.084
|
Human |
|
|
glucose transport
|
GO:0015758 |
56 |
0.083
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.083
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.082
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.082
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.081
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.081
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.080
|
Human |
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.080
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.080
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.079
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.079
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.078
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.078
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.078
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.078
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.077
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.077
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.076
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.076
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.076
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.076
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.075
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.074
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.074
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.074
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.074
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.074
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.073
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.073
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.073
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.073
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.072
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.072
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.071
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.071
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.070
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.070
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.069
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.069
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.069
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.068
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.068
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.068
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.068
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.067
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.067
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.067
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.066
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.065
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.065
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.065
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.065
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.065
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.065
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.064
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.064
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.064
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.063
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.063
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.063
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.063
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.063
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.063
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.062
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.062
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.062
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.062
|
|
|
|
aminoglycan biosynthetic process
|
GO:0006023 |
15 |
0.061
|
|
|
|
memory
|
GO:0007613 |
58 |
0.061
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.060
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.059
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.059
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.059
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.058
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.058
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.058
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.058
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.058
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.058
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.057
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.057
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.057
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.057
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.057
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.056
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.055
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.055
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.055
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.055
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.055
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.054
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.054
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.054
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.054
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.053
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.053
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.053
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.053
|
|
|
|
negative regulation of release of cytochrome c from mitochondria
|
GO:0090201 |
6 |
0.053
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.052
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.052
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.052
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.051
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.051
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.051
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.051
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.050
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.050
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.050
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.050
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.050
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.050
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.050
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.049
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.049
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.049
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.049
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.049
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.049
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.049
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.049
|
|
|
|
prostate glandular acinus morphogenesis
|
GO:0060526 |
7 |
0.048
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.048
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.048
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.048
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.047
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.047
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.047
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.047
|
|
|
|
glycogen biosynthetic process
|
GO:0005978 |
14 |
0.047
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.047
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.047
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.047
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.047
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.047
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.047
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.046
|
Human |
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.046
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.046
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.046
|
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
11 |
0.045
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.045
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.045
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.045
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.045
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.045
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.045
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.045
|
Human |
|
|
response to nicotine
|
GO:0035094 |
6 |
0.045
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.045
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.044
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.044
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.044
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.044
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.044
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.044
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.044
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.044
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.044
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.043
|
|
|
|
male courtship behavior
|
GO:0008049 |
2 |
0.043
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.043
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.043
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.043
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.042
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.042
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.042
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.042
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.042
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.042
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.042
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.042
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.042
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.042
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.042
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.042
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.041
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.041
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.041
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.041
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.041
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.041
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.041
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.041
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.040
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.040
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
27 |
0.040
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.040
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.040
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.040
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.040
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.040
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.039
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.039
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.039
|
Human |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.039
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.039
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.039
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.039
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.039
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.038
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.038
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.038
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.038
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.038
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.038
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.038
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.038
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.037
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.037
|
|
|
|
branching involved in prostate gland morphogenesis
|
GO:0060442 |
15 |
0.037
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.037
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.036
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.036
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.036
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.036
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.036
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.036
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.035
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.035
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.035
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.035
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.035
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.035
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.035
|
|
|
|
regulation of phosphatidylinositol 3 kinase activity
|
GO:0043551 |
14 |
0.035
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.035
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.035
|
|
|
|
polysaccharide biosynthetic process
|
GO:0000271 |
20 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase activity
|
GO:0043552 |
11 |
0.034
|
|
|
|
formation of anatomical boundary
|
GO:0048859 |
6 |
0.034
|
|
|
|
glycosaminoglycan biosynthetic process
|
GO:0006024 |
15 |
0.034
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.034
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.034
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.033
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.033
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.033
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
regulation of glycogen starch synthase activity
|
GO:2000465 |
5 |
0.033
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.033
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.033
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.033
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.033
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.033
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.032
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.032
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.032
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.032
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.032
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.032
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.032
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.032
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.032
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.032
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.032
|
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.032
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.032
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.032
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.032
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.031
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.031
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.031
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.031
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.031
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
positive regulation of receptor activity
|
GO:2000273 |
17 |
0.031
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.031
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.031
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.031
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.031
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.030
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.030
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.030
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.030
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.030
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.030
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.030
|
|
|
|
glucan biosynthetic process
|
GO:0009250 |
14 |
0.030
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.030
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.030
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.030
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.030
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.030
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.030
|
Human |
|
|
gland development
|
GO:0048732 |
330 |
0.029
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.029
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.029
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.029
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.029
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.029
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.029
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.029
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.029
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.029
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.029
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.028
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.028
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.028
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.028
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.028
|
|
|
|
insulin receptor signaling pathway via phosphatidylinositol 3 kinase
|
GO:0038028 |
3 |
0.028
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.028
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.027
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.027
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.027
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.027
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.027
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.027
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.027
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.027
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.027
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.027
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.026
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.026
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.026
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.026
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.026
|
|
